BCR and diffuse large B-cell lymphoma: Herein, we identified potential subtypes by performing clustering analysis of the downstream components of BCR signaling pathways in PB-DLBCL patients, and then characterized each cluster in order to predict therapeutic effects as well as the prognostic survival of PB-DLBCL patients.